Gregg Fonarow MD(@gcfmd) 's Twitter Profileg
Gregg Fonarow MD

@gcfmd

ID:1035490068

calendar_today25-12-2012 19:55:28

9,3K Tweets

10,8K Followers

144 Following

Alison L. Bailey, MD(@a_l_bailey) 's Twitter Profile Photo

residents consistently have worse CVD outcomes than others. This is 💔 for a KY/TN girl.

Example for from recent alarming letter from Gregg Fonarow MD looking at hf outcomes. We must improve and help our partners!

jamanetwork.com/journals/jamac…

#Rural residents consistently have worse CVD outcomes than others. This is 💔 for a KY/TN girl. Example for #HeartFailure from recent alarming letter from @gcfmd looking at hf outcomes. We must improve and help our partners! jamanetwork.com/journals/jamac…
account_circle
Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

. , one of the most highly anticipated trials of yr, to be presented

Sema 1.0mg once weekly *disease modifying* in CKD+T2D
✅ ↓ Composite kidney events
✅ Slower eGFR decline
✅ ↓ MACE
✅ ↓ All-cause mortality

A new era, firmly establishes 4th pillar in !

.#FLOW, one of the most highly anticipated #CKM trials of yr, to be presented #ERA24 Sema 1.0mg once weekly *disease modifying* in CKD+T2D ✅ ↓ Composite kidney events ✅ Slower eGFR decline ✅ ↓ MACE ✅ ↓ All-cause mortality A new era, firmly establishes 4th pillar in #CKD!
account_circle
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

What do you predict for age-adjusted HF-related mortality in 2022, 2023, and 2024?

Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021 jamanetwork.com/journals/jamac…

JAMA Cardiology JAMA

account_circle
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

Cost effectiveness analysis of 💊 Rx in HFmrEF/HFpEF

Timing of generic pricing is 🔑

Cost-Effectiveness of Medical Therapy for Heart Failure With Mildly Re... sciencedirect.com/science/articl…

Boback Ziaeian 🤦🏻‍♂️ Neal Dixit, MD JACC Journals

Cost effectiveness analysis of 💊 Rx in HFmrEF/HFpEF Timing of generic pricing is 🔑 Cost-Effectiveness of Medical Therapy for Heart Failure With Mildly Re... sciencedirect.com/science/articl… @boback @NealDixit @JACCJournals
account_circle
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

Advancing HF stages were associated with increasing risk mortality

Development and implementation of early screening and targeted interventions are urgently needed to reduce HF burdens in China

Prognostic implications of HF stages among Chinese... sciencedirect.com/science/articl…

account_circle
John M. Clymer(@JohnClymer) 's Twitter Profile Photo

We have the tools & know-how to bend this curve ⤵️.

✅ and manage
✅ and manage blood glucose
🚭 discourage
🚶‍♀️ encourage & empower active living

Begin preventive screenings and treatments early in life.

American Journal of Preventive Medicine (AJPM) American Journal of Hypertension AJPH

account_circle
Cardiology Today(@CardiologyToday) 's Twitter Profile Photo

“Recent data suggest plateaus or reversals after long-standing declines in cardiovascular mortality, particularly for HF-related mortality” JAMA Cardiology

Read more👇
healio.com/news/cardiolog…

account_circle
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

How have HF mortality rates changed from 1999-2021 in the US?

From 1999-2012
↘ : Decline by ~25%

From 2012-2021
↗ Reversals that have now undone ALL initial declines.

🚨HF mortality in 2021 > HF mortality in 1999 🚨

jamanetwork.com/journals/jamac…

Marat Fudim, MD MHS Ahmed Sayed HFSA

account_circle
JAMA Cardiology(@JAMACardio) 's Twitter Profile Photo

Analysis shows that initial declines in HF-related mortality from 1999 to 2012 have been entirely undone by subsequent reversals from 2012 to 2021, meaning that contemporary HF mortality rates are higher than in 1999. ja.ma/3UcwM23

Analysis shows that initial declines in HF-related mortality from 1999 to 2012 have been entirely undone by subsequent reversals from 2012 to 2021, meaning that contemporary HF mortality rates are higher than in 1999. ja.ma/3UcwM23
account_circle
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

HFrEF ↘️↘️↘️median survival 7-18 years

GDMT ↗️↗️↗️ median survival:

✅ ARNI 2-3 yrs (1-2 yrs vs ACEI or ARB)
✅ BB 3-4 yrs
✅ MRA 2-3 yrs
✅ SGLTi 1-2 yrs

Clinical benefits non-overlapping, incremental, additive

Quadruple >>>triple>>>double

Fast >>>>slow

Now>>>later

HFrEF ↘️↘️↘️median survival 7-18 years GDMT ↗️↗️↗️ median survival: ✅ ARNI 2-3 yrs (1-2 yrs vs ACEI or ARB) ✅ BB 3-4 yrs ✅ MRA 2-3 yrs ✅ SGLTi 1-2 yrs Clinical benefits non-overlapping, incremental, additive Quadruple >>>triple>>>double Fast >>>>slow Now>>>later
account_circle
Ahmed Sayed(@ASayedMD) 's Twitter Profile Photo

What now❓

⏫ Interventions to prevent HF

⏫ Interventions to treat HF

⏫ Wider & equitable access (potential role for remote patient care?)

❓ Revisit potentially problematic policies

🔬 Revisit impact of pandemic on healthcare

account_circle
Ahmed Sayed(@ASayedMD) 's Twitter Profile Photo

How have HF mortality rates changed from 1999-2021 in the US❓

From 1999-2012📉: Decline by ~25%
From 2012-2021📈: Reversals that have now undone ALL initial declines.

Result: HF mortality in 2021 > HF mortality in 1999 ‼️

Link to our work JAMA Cardiology : jamanetwork.com/journals/jamac…

How have HF mortality rates changed from 1999-2021 in the US❓ From 1999-2012📉: Decline by ~25% From 2012-2021📈: Reversals that have now undone ALL initial declines. Result: HF mortality in 2021 > HF mortality in 1999 ‼️ Link to our work @JAMACardio : jamanetwork.com/journals/jamac…
account_circle
Ahmed Sayed(@ASayedMD) 's Twitter Profile Photo

Why❓

Potential culprits:

1⃣ ⏫ metabolic disease ➡️ ⏫ HF prevalence

2⃣ 🚫care access ➡️ 🚫GDMT ➡️ ⏫ HF mortality

3⃣ HRRP ➡️ bad incentives ➡️ ⏫ HF mortality

4⃣COVID (exacerbating) ➡️ healthcare interruptions +/- 🫀involvement ➡️ ⏫ HF prevalence/mortality

account_circle